Antibiotic prophylaxis in urological surgery, a European viewpoint.
(2011) In International Journal of Antimicrobial Agents 38. p.58-63- Abstract
- Surgical site infections (SSI) including urinary tract infections (UTI) cause a significant morbidity in urological surgery. Antibiotic prophylaxis is one of several factors impacting on infection rates. Antibiotic prophylaxis is relevant only for clean and clean-contaminated operations and in the absence of bacterial growth in the urine. Strict classification of urological procedures is lacking, but a proposal is presented elsewhere. Only TURP and transrectal core prostate biopsy are well documented. The present review confirms that there is a lack of hard data, insufficient consistency in classification and definitions, and that new well-powered RCT and large multicentre quality cohort studies including risk factor analysis are necessary... (More)
- Surgical site infections (SSI) including urinary tract infections (UTI) cause a significant morbidity in urological surgery. Antibiotic prophylaxis is one of several factors impacting on infection rates. Antibiotic prophylaxis is relevant only for clean and clean-contaminated operations and in the absence of bacterial growth in the urine. Strict classification of urological procedures is lacking, but a proposal is presented elsewhere. Only TURP and transrectal core prostate biopsy are well documented. The present review confirms that there is a lack of hard data, insufficient consistency in classification and definitions, and that new well-powered RCT and large multicentre quality cohort studies including risk factor analysis are necessary to improve recommendations for antibiotic prophylaxis in urologic surgery. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2200535
- author
- Grabe, Magnus LU
- organization
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- subject
- in
- International Journal of Antimicrobial Agents
- volume
- 38
- pages
- 58 - 63
- publisher
- Elsevier
- external identifiers
-
- wos:000298141200008
- pmid:21996404
- scopus:82655173802
- pmid:21996404
- ISSN
- 1872-7913
- DOI
- 10.1016/j.ijantimicag.2011.09.008
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pediatrics/Urology/Gynecology/Endocrinology (013240400)
- id
- 36bb5300-190e-425e-9881-976a5d188058 (old id 2200535)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/21996404?dopt=Abstract
- date added to LUP
- 2016-04-04 08:11:55
- date last changed
- 2022-01-29 03:05:19
@article{36bb5300-190e-425e-9881-976a5d188058,
abstract = {{Surgical site infections (SSI) including urinary tract infections (UTI) cause a significant morbidity in urological surgery. Antibiotic prophylaxis is one of several factors impacting on infection rates. Antibiotic prophylaxis is relevant only for clean and clean-contaminated operations and in the absence of bacterial growth in the urine. Strict classification of urological procedures is lacking, but a proposal is presented elsewhere. Only TURP and transrectal core prostate biopsy are well documented. The present review confirms that there is a lack of hard data, insufficient consistency in classification and definitions, and that new well-powered RCT and large multicentre quality cohort studies including risk factor analysis are necessary to improve recommendations for antibiotic prophylaxis in urologic surgery.}},
author = {{Grabe, Magnus}},
issn = {{1872-7913}},
language = {{eng}},
pages = {{58--63}},
publisher = {{Elsevier}},
series = {{International Journal of Antimicrobial Agents}},
title = {{Antibiotic prophylaxis in urological surgery, a European viewpoint.}},
url = {{http://dx.doi.org/10.1016/j.ijantimicag.2011.09.008}},
doi = {{10.1016/j.ijantimicag.2011.09.008}},
volume = {{38}},
year = {{2011}},
}